Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II study
呋喹替尼联合吉非替尼作为一线疗法治疗携带 EGFR 突变的晚期非小细胞肺癌患者:一项单臂 II 期研究
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-20-1028
Lu, Shun; Zhou, Jian-Ying; Niu, Xiao-Min; Zhou, Jian-Ya; Jian, Hong; Yin, Hong-Yan; Guan, Sha; Wang, Lin-Fang; Li, Ke; He, James; Su, Wei-Guo